Notes
2016 US dollars
Reference
WAHLQVIST P, et al. Meta-analysis vs. Single Trial (OpT2mise Study) Data to Assess Cost-Effectiveness of Simple CSII Devices in T2DM in the U.S. 78th Annual Scientific Sessions of the American Diabetes Association : abstr. 978-P, 22 Jun 2018. Available from: URL: https://plan.core-apps.com/tristar_ada18/abstract/807d2f9885450670bb994661e35ce668
Rights and permissions
About this article
Cite this article
Continuous subcutaneous insulin infusion cost effective in T2DM. PharmacoEcon Outcomes News 808, 13 (2018). https://doi.org/10.1007/s40274-018-5128-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5128-3